AI-generated analysis. Always verify with the original filing.
Imunon, Inc. filed a prospectus supplement on March 23, 2026, to register an additional $7,000,000 of common stock shares issuable under its At the Market Offering Agreement with H.C. Wainwright & Co., LLC, increasing the total registered amount to $17,000,000 from $10,000,000. Prior to the filing, $4,797,848 of common stock had been sold under the agreement.
Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On March 23, 2026, Imunon, Inc. (the “Company”) filed a prospectus supplement (the “Prospectus Supplement”) to register an additional $7,000,000 o
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.1 Opinion of Thompson Hine LLP. 23.1 Consent of Thompson Hine LLP (included in Exhibit